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Simple Practices to Facilitate the Flow of Valuable Tacit 
Knowledge during Biopharmaceutical Technology Transfer:  




Martin Lipa, MSD,  TU Dublin,  PRST 
Paige Kane, MSD,  PRST 
Anne Greene, TU Dublin, PRST 
 
Abstract 
The biopharmaceutical industry is regarded as a knowledge industry.  However, in general, 
the industry is not effective at managing its knowledge as an asset across the product lifecycle, 
including during fundamental processes such as technology transfer.   This is true in particular 
for tacit knowledge (e.g., know-how), where tacit knowledge it considered critical to the 
success of technology transfer, yet tacit knowledge transfer is somewhat ineffective.  This can 
lead to the introduction of risk and other undesirable outcomes.  This paper profiles a case 
study in tacit knowledge flow where a series of pragmatic practices were deployed during a 
complex vaccine drug substance technology transfer.  These practices demonstrated 
improvements in tacit knowledge flow as evidenced by learning, process improvements and 
gaps in knowledge identified, which were subsequently addressed to reduce risk, increase 
product and process understanding, improve robustness, and define future development 
needs.   Common success factors for these simple practices are explored through the case 
study.  A key takeaway is that such knowledge transfer processes do not need to be complex 
nor onerous in order to achieve tangible improvements in knowledge transfer effectiveness.   
 
1. Introduction 
The biopharmaceutical industry is a knowledge industry with its intensive use of technology 
and human capital [1].  Indeed a biopharmaceutical company’s long-term viability flows from 
its ability to develop, apply and grow knowledge about products and processes while ensuring 
sufficient supply of safe, efficacious and cost-effective products to the marketplace.  Thus, 
knowledge is an asset to the company and as such, there is value in managing knowledge 
assets in the same way as physical assets [2].   
 
Standard Knowledge Management (KM) practices1 can be used as a means to improve the 
effectiveness of how knowledge is managed as an asset and how knowledge flows through 
an organization [3].  Ideally, for a biopharmaceutical product, knowledge must flow across 
the entire lifecycle from product development through to product discontinuation [4].  Yet 
research has shown that the current effectiveness of knowledge management in the 
biopharmaceutical industry is lacking [2].  Knowledge is not managed as an asset, does not 
flow freely, and ‘leaks’ from the organization through a variety of means, including [5], [6]: 
                                                 
1 The term ‘practice’ refers to the collective approach or methodology used, typically consisting of 
considerations for people (e.g., roles and mindsets), process, technology and governance   
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• employee turnover 
• inconsistent expectations and processes for knowledge capture 
• sub-optimal capture and use of lessons learned 
• organizational ‘silos’ 
• ineffective knowledge transfer between people and/or functional groups)  
This ‘leakage’ is especially true given the long cycle times associated with the 
biopharmaceutical product lifecycle, large number of people involved, highly complex 
processes, and typically global distributed nature of research, manufacturing, and supply 
chain organizations.   
 
A recent study by the authors on the importance of knowledge transfer for the sustained 
success of technology transfer found that the transfer of explicit knowledge (e.g. documents) 
and tacit knowledge (e.g. ‘know-how’) were both extremely important to successful 
technology transfer.  However in gauging knowledge transfer effectiveness, the transfer of 
explicit knowledge was found to be only marginally effective.  The transfer of tacit knowledge 
fared worse, as it was considered somewhat ineffective [5].  
 
This paper presents a brief introduction to tacit knowledge as related to the 
biopharmaceutical industry and its importance to technology transfer.  This is followed by a 
case study profiling a series of practices to facilitate tacit knowledge transfer during a new 
product introduction technology transfer, along with the results achieved.   
 
2. ‘Tacit knowledge’ and its importance 
Some definitions of tacit knowledge refer to philosophical or abstract concepts.  A common 
example is the knowledge of how to ride a bike.  How do you know this, and how would you 
describe this to someone else?  Polanyi is credited with the term tacit knowledge in his 1966 
book, the Tacit Dimension, and the related observation that “we know more than we can tell.” 
[7] 
 
Tacit knowledge can be defined as skills, ideas and experiences that people have but are not 
codified and may not necessarily be easily expressed [8].  With tacit knowledge, people are 
not often aware of the knowledge they possess or how it can be valuable to others.  Effective 
transfer of tacit knowledge generally requires extensive personal contact, regular interaction, 
and trust [9].   A tangible example of this is the journeyman and apprentice, where the 
apprentice is coached over an extended period by the highly skilled and experienced 
journeyman.  In fact, 70% to 80% of the collective knowledge in biopharmaceutical companies 
is tacit knowledge [10], [11] yet these assets are not managed well. 
 
In contrast to explicit knowledge, which is commonly regarded as know-what (i.e., facts), tacit 
knowledge can be described as know-how.  In the limited references to tacit knowledge 
currently embedded in biopharmaceutical literature, know-how is the most common 
expression representing tacit knowledge, along with related concepts of experienced and 
expert [4], [12]–[15]. 
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In addition, the concepts of know-why and know-who can also be considered tacit knowledge 
[16], and the authors find the illustration in Figure 1 by shared Brinson [17] useful to depict 
this visually by linking knowledge to actions.  In particular, the inner relationships of insight 
(know-what + know-why), reaction (know-why + know-how) and method (know-what + 
know-how) are of clear and inherent value to knowledge work of the biopharmaceutical 




Figure 1 – Know-What, Know-Why and Know-How [17] 
 
Knowing what, why and how empowers the decision maker with the best available knowledge 
on hand, to take the most meaningful actions to manage risk to both the patient and the 
business.  Ensuring this knowledge is available and is applied is key as demonstrated in the 
Risk-Knowledge Infinity Cycle described in 2020 by Lipa et al [18].  This framework (Figure 2) 
highlights the relationship between knowledge and risk:  As knowledge increases, risk 
decreases.  This is accomplished in part by ensuring the effective flow of knowledge in-to and 
out-of risk management and other business processes. 
 
Figure 2 - The Risk-Knowledge Infinity Cycle [18] 
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3. Tacit knowledge and technology transfer  
This paper focuses on a biopharmaceutical product technology transfer and describes 
pragmatic practices to enable the capture and transfer of tacit knowledge (i.e., technical 
know-how and know-why, and to a lesser extent know-who).  This case study demonstrates 
how relatively simple practices can have a strong impact on how knowledge is managed as an 
asset and in turn reduces risk to the patient. 
 
The bias toward explicit knowledge and general neglect of tacit knowledge is perhaps not 
surprising in an industry with the informal mantra “if it isn’t written down, it didn’t happen”, 
as often reinforced by GMP (Good Manufacturing Practice) training.  Yet, critical tacit 
knowledge is expected to be transferred during technology transfer by industry experts and 
regulatory agencies alike, including key development activities, learnings from failures, pilot 
scale knowledge, how to run a process in a particular piece of equipment, how risk is 
communicated, etc. [5].   
 
According to APQC, “knowledge is sticky, and without a process it will not flow” [11].  There 
are a variety of common knowledge management practices which can facilitate the structured 
transfer of tacit knowledge, including: 
• social networks  
• storytelling 
• shadowing of experts 
• lessons learned / after action review 
• communities of practice 
• and others   
However, these practices are not commonly employed during technology transfer within the 
biopharmaceutical sector.  Instead, typically there are unstructured practices used to transfer 
tacit knowledge in a highly ad hoc manner.  For example, where a receiving site representative 
may observe a batch being manufactured at the sending site prior to transfer.  Facility fits, 
process walkthroughs and risk assessments are other means where some tacit knowledge is 
transferred, although typically in an ad hoc manner.   
 
The following case study presents examples of three structured KM practices which were 
shown to be effective in enabling tacit knowledge flow during a new product introduction.   
 
4. Case Study:  Three (3) practices to improve tacit knowledge flow during 
technology transfer 
Recognizing the importance of tacit knowledge and the general ineffectiveness of tacit 
knowledge transfer, an effort was undertaken during a technology transfer at a major multi-
national biopharmaceutical company to improve tacit knowledge transfer in support of on-
time filing and commercial launch of a new therapy.  It is important to note the case study 
example is a highly complex vaccine drug substance product which resulted in a large number 
of process performance qualification (PPQ) batches (i.e., there were a large number of 
validation batches, many more than the typical 3).  The transfer was a new product 
introduction from a late-stage development organization to the full-scale commercial 
manufacturing facility within the innovator company.   Due to typical aggressive technology 
4
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transfer timescales and resource constraints, the tactics for tacit knowledge capture and 
transfer had to be as pragmatic as possible for the technology transfer team.  
 
Drawing on best practices in knowledge management, each of the tacit knowledge transfer 
practices reviewed in this case study share common elements, including: 
• Standardized business process for knowledge capture and transfer (and codification to explicit 
knowledge, where appropriate) 
• Basic governance to ensure prioritization and follow through on important actions 
• Enabling mindsets for sending and receiving site personnel, including ‘safe to share’ and a 
sense of inquisitiveness. This included active engagement and participation from people, 
including experts from the sending site and members from the receiving site 
In addition, each practice featured a targeted set of open-ended questions to foster dialogue, 
tailored to the context at hand.   
 
The three practices developed and utilized in this case study were:  
1. What if…? 
2. Technology Transfer Batch Execution Review 
3. Tacit Knowledge Turnover Assessment 
 
4.1. What If…? 
Process overview 
The What if…? practice for knowledge transfer is a form of a risk assessment [19].   
 
In this case study using What if…?, the technology transfer team took a stepwise approach to 
interrogate the process in a structured manner by asking the sending site subject matter 
expert (SME):   
 
“What if <operating parameter x> exceeds it’s typical range?”  
 
This was followed by a discussion on what evidence existed to support this knowledge.  This 
process explored what would happen at the typical high and low range limits and was 
repeated for each operating parameter.   
 
This practice was not intended to replace a formal quality risk assessment, but rather to 
enhance dialogue amongst a broader team through a lens of discovering “what is known” and 
“how do we know it?”.  Figure 3 provides a process overview, including illustrative questions 
asked as part of this process.  
5
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Figure 3 – “What If...?" Process Overview 
 
How the process helped with tacit knowledge transfer (“learn before”) 
The What if…? practice, deployed by the receiving site-based technology transfer team, 
created important dialogue between the SMEs of the sending site and the new process team 
at the receiving site in exploring what is known about the performance of each operating 
parameter at the boundary of its limits.  This included the identification and transfer of 
relevant supporting evidence (knowledge) which may not have been otherwise transferred.   
 
This line of questioning also allowed the team to engage in rich discussion about ‘known 
unknowns.’  In other words – known gaps in knowledge – such as areas not previously studied.  
This enabled the receiving site to better understand risks, areas of uncertainty, process 
sensitives, and inform future process development opportunities.  The dialogue that 
emerged created a powerful learning opportunity for the receiving site, enabling the team to 
“learn before” process execution.   
 
Results  
In this case study, the What if… practice identified over 100 potential actions which were 
grouped into key categories of: 
• Process knowledge (67%) 
• No data exists (16%) 
• Equipment knowledge (11%) 
• Other (6%) 
Of these, a vast majority (84%) were actioned, indicating the site recognized the value in 
addressing the gaps and closing them.  A tracking mechanism with basic metrics and regular 
review with the technology transfer leadership team (a governance body) were key enablers 
to ensure this knowledge was acted upon and built back into the flow of the work.   
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4.2. Technology Transfer Batch Execution Review 
Process overview 
For this technology transfer, the authors developed a new practice, named by the authors as 
the Technology Transfer Batch Execution Review (TT-BER).  TT-BER consists of two parts: 
 
1. A pre-batch review, based on concepts found in a pre-job brief.  A pre-job brief is a practice 
often used in safety management processes involving high hazard and/or complex work 
activities [20], [21] 
2. A tailored After Action Review (AAR) [22], serving as a post-batch review 
 
This pairing of reviews both before and after batch execution create a closed loop cycle 
supporting risk mitigation, learning and continuous improvement.   
 
In this case study, the technology transfer team huddled prior to execution of each PPQ batch 
to conduct a pre-batch review.  As part of this pre-batch review, the team reviewed key 
questions including: 
 
• “What does good look like for our planned activity?” 
• “What changed since last time?”  
• “What is new, unique or difficult?” 
An illustrative set of questions is included in Figure 4.   
 
The back end of the TT-BER practice was the post-batch review.  Practically speaking, this was 
an after-action review tailored to the context of a batch execution.  The technology transfer 
team paused to reflect, drawing on after-action review best practices to explore a series of 
key questions culminating with  
 
• “What can we learn?”  
• “Who needs to know?” 
 
An illustrative set of after-action review questions is included in Figure 4.   
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Figure 4 – Technology Transfer Batch Execution Review (TT-BER) Process 
 
How the process helped with tacit knowledge transfer (“learn during”) 
As discussed above, the TT-BER practice with pre-batch review and after action review 
activities was newly conceived for this technology transfer project.  The TT-BER ˆ provided a 
powerful opportunity for the technology transfer team to come together and surface 
assumptions, changes, areas of concern and other tacit knowledge held by the team members 
in anticipating batch execution.  Given this case study involved a new product introduction, 
significant learning occurred involving the equipment and the process.  In particular, the 
context of the upcoming batch execution and what was known from the prior batch created 
strong situational awareness for the team, enabling the team to better focus on successful 
execution of the task at hand.   
 
The TT-BER AAR (post-batch review) similarly provided a structured opportunity for the team 
to pause and reflect on what actually happened versus what was intended to happen.  The 
open-ended questions on understanding why the actual outcome were not the same as 
intended (whether for better or worse) and transforming this insight into an actionable 
lesson.  These insights drove tangible learning and improvement actions which were tracked 
via the governance process.  Through these reviews with associated dialogue, the TT-BER 
process enabled the receiving site to “learn during” process execution in a very agile and 
adaptive manner through the enhanced knowledge transfer. 
 
Results  
The metrics associated with the TT-BER practice are telling.  The process produced 82 
potential actions.  Of these: 
 
• 52 were implemented (63%) 
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• 16 were tagged as future continuous improvement opportunities (20%) 
• 11 were not applicable (e.g. duplicates, once-off, etc.) (13%) 
• 3 were managed through the formal quality system (4%)   
 
A qualitative review of the 52 actions implemented revealed that 43 of the 52 could have 
potentially led to a deviation in the quality system had they not been proactively addressed.  
For example, to conduct additional studies to extend hold times and thus mitigate future 
deviations once the process execution cycle time and other logistics were better understood.   
 
This demonstrated a powerful example of proactive risk mitigation and associated positive 
impact to right-first-time execution, improved quality, reduced cost, and reduced lead time.  
Furthermore, testimonials from the technology transfer team enthusiastically supported 
these outcomes.  The production area lead noted:  
 
“the process enabled process improvement on a near real-time basis for items that 
may have lingered for years. While items that were necessary to ensure ‘ready for 
launch’ would have been captured, ‘ready for supply’ items may have been missed.”   
 
This was a clear testament to the impact of TT-BER on the process robustness and future 
manufacturability.   
 
A further endorsement from the technology organization was as follows:  
 
“After action review provided the required environment to generate an ambitious 
continuous improvement recommendation to run small scale studies to extend the 
proven acceptable range…not restricted by timeline & system.  After action review 
allowed time to ‘fix’ [potential issues].” 
 
A tracking mechanism with basic metrics and regular review with the technology transfer 
leadership team who provided appropriate governance were key enablers.  This practice was 
further recognized at the corporate manufacturing division by being awarded the winner of a 
highly competitive award for innovation.   
 
4.3. Tacit Knowledge Turnover Assessment 
Process overview 
For this technology transfer, the authors developed a second new practice, named by the 
authors as the Tacit Knowledge Turnover Assessment (TKTA).  The authors intent was to 
conceive a means to create further dialogue to reflect on understanding, uncertainty and risk 
to augment the standardized post-campaign after action review.  While the after action 
review would focus on learning from the technology transfer and associated business process, 
TKTA was intended to focus on product and process insights.    
 
TKTA is a simple reflection process to evaluate the ‘big picture’ after PPQ batches were 
complete but prior to attrition of the sending site subject matter experts (or their memories).  
The sending site and receiving site selected their top 5 to 10 questions from a list of about 25 
potential questions.  Each group reflected on the questions independently and then met 
9
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together to review as a team and agree on actions.  Figure 5 provides a process overview and 
illustrative questions used to prompt dialogue amongst the team.   
 
 
Figure 5 – The Tacit Knowledge Turnover Assessment (TKTA) Process 
 
How the process helped with tacit knowledge transfer (“learn after”) 
As discussed above, the TKTA practice to capture tacit knowledge was newly conceived for 
this technology transfer project.  Similar to the other practices deployed prior, this practice 
also facilitated rich dialogue amongst the team members, providing a process, a time and a 
context to explore and exchange tacit knowledge.  The perspective of this process was 
prompting the team to ‘zoom out’ to the big picture with the PPQ batches completed.  As the 
questions in Figure 5 illustrate, they are intended to explore un-met expectations, sources of 
uncertainty, concerns, and future opportunities.  This practice enabled the receiving site to 
engage in candid, transparent dialogue and to “learn after” completion of the technology 
transfer activities.   
 
Results 
Similar to the What if…? process, the dialogue that emerged provided rich insights to inform 
risk, training of staff and future process development opportunities.  In this case, the team 
identified 70 “answers” to the questions posed as part of the process.  These 70 answers 
resulted in 39 actions taken to close gaps.  These gaps were grouped into key categories of: 
• Unexpected from PPQ (20%) 
• What keeps you up at night (20%) 
• Process improvement opportunities (17%) 
• Learnings to share from key failed experiments (12%) 
• Items that are least repeatable (8%) 
• ‘Rules of thumb’ to capture (7%) 
• Other (areas to study more, things not understood from PPQ, rationale from past decisions) 
 
This TKTA process was conducted in addition to a formal after-action review and generated 
additional valuable insights and opportunities as it provided a different line of questioning 
than a traditional AAR.  A tracking mechanism with basic metrics and regular review with the 
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technology transfer leadership team who provided appropriate governance were key 
enablers.   
 
5. Additional practices to facilitate tacit knowledge flow during technology 
transfer 
While this case study presents three practices focused exclusively on tacit knowledge for 
technology transfer, the authors acknowledge there are several additional KM practices 
which can be highly beneficial in facilitating tacit knowledge transfer.  For each, a standard 
process, supporting tools and templates, a mindset to manage knowledge as an asset and 
appropriate governance are critical success factors.  Table I below outlines a series of 
additional KM practices which may be beneficial.   
 
Table I - Additional KM practices for tacit knowledge 
KM Practice Description relative to technology transfer 
Retention of critical 
knowledge 
The retention of critical knowledge process is a risk assessment and risk 
management process to mitigate the impact of employee turnover, especially highly 
experienced staff with unique, ‘mission critical’ knowledge.  This process can be 
applied during technology transfer (e.g. if experts leave the project or the 
organization) and/or selectively at the end of the technology transfer before experts 
move on to new assignments.   The retention of critical knowledge process starts 
with a risk assessment of the individual’s knowledge to help objectively define and 
prioritize areas of highest risk (what knowledge is critical or unique to this 
individual).  Once prioritized topics are identified, the process guides the manager 
and expert through a series of facets of expertise to evaluate including know-what, 
know-how, know-who, and know-why.  Knowledge transfer happens primarily during 
dialogue between expert and (ideally) successor or other expert, and through new 
knowledge assets created in response to the prioritized risks (e.g., white papers, 
training modules, product histories or other critical knowledge). 
After-action review 
(AAR) 
After action review, and closely related KM practice of lessons learned, are well-
characterized processes [22] which focuses on extracting lessons from projects or 
events (what went well, in addition to what did not go well) and to ensure better 
performance on future project through targeted process improvements.   
Decision Trackers Simple lists of key decisions with supporting rationale (e.g. assumptions, choices 
evaluated, selection criteria and reasoning) can be beneficial to the receiving unit, 
who would not typically have understanding or visibility to these details ‘looking 
back’ in the future.  This tacit knowledge can help with investigations, risk 
management, and development opportunities at a minimum 
Subject Matter 
Expert (SME) Listing 
Simple lists of who the subject matter experts are for a given product and process 
can be a valuable resource for future reference. 
Communities of 
Practice (CoPs) 
Communities of practice are powerful venues to connect diverse sets of people with 
areas of common interest.  For technology transfer, a community focused on the 
process of technology transfer itself can help support the effective execution of the 
business process for technology transfer.  Further, topic-specific communities (e.g. 
platform technologies) can also be invaluable to support technology transfer, 
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6. Discussion 
The three knowledge transfer practices described in the case study, taken in aggregate, 
allowed the receiving site to “learn before, learn during and learn after” the technology 
transfer project, benefiting both the technology transfer at hand, the future of the product at 
the site, and future technology transfer projects.  The sending site is also likely to benefit in 
understanding their effectiveness at capturing and transferring knowledge, creating a 
learning opportunity for future projects.  This rich tacit knowledge sharing also enables the 
receiving site to go beyond the routine “minimal viable knowledge” typically shared as part 
of a technology transfer project.  Currently, this knowledge sharing tends to be heavily biased 
to explicit knowledge – and is especially so when faced with the schedule, cost, and resource 
pressures of technology transfer projects.  When an organization realizes the potential impact 
of these tacit knowledge transfer practices on the overall technology transfer and long-term 
manufacturability of the product, the benefit becomes obvious.   
 
These processes share common success factors, including a standard process, open ended 
questions to foster dialogue, basic governance, supporting mindsets and active engagement.  
Exhibiting the mindsets and active engagement to share important tacit knowledge during 
technology transfer also demonstrates a fundamental behaviour of ‘a culture of knowledge 
excellence.’  A ‘culture of knowledge excellence’ (i.e. ‘knowledge culture’) emphasizes “A way 
of organizational life that enables and motivates people to create, share and utilize 
knowledge for the benefit and enduring success of the organization.” [23]  This knowledge 
culture is further characterized by the boundaryless flow of knowledge, a culture of inclusion, 
a sense of curiosity, a growth mindset and a desire to capture, share and grow knowledge 
across the organization [24].   As an example of the potential impact, a study in Harvard 
Business Review reported that workers who take time to reflect perform more than 20% 
better than those who do not pause to reflect [25].   
 
There are limitations to these processes.  These processes by no means guarantee a perfect 
technology transfer and they do impact on the time of key staff to execute.  Therefore, they 
must be appropriately sponsored by management and applied in a “fit for purpose” manner 
and at the right time.  Resulting actions must be prioritized.  The critical success factors 
discussed cannot be overlooked (including governance).  In addition, while these practices 
focus on tacit knowledge transfer, one must not forget there are other activities required for 
explicit knowledge transfer (and the need for further enhancement).   
 
7. Conclusion 
Significant strides can be made in tacit knowledge transfer during technology transfer as 
described in this case study and participant feedback.  These processes aren’t overly complex,  
onerous, or mysterious.  Rather they are about a basic commitment and discipline to create 
a time, space, and context for people to engage in dialogue, facilitated by open-ended, 
probative questions to surface knowledge.   
 
This tacit knowledge also includes assumptions, insights, decision rationale or other 
knowledge which may well be obvious to the experienced sending site or SME but are likely 
not so obvious to the receiving site staff.  As the saying goes, “You don’t know what you know 
until you are asked a question.”  These simple processes when embedded in routine work do 
12
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just that:  They provide a process for knowledge to flow, and through the case study 
presented above, have demonstrated clear benefits to proactive risk mitigation, improved 
quality and higher right first time PPQ batches.  In addition, there are long term benefits 
anticipated, including improved process robustness and increased knowledge available to 
inform risk-based decision making.  And while this case study indeed focused on a highly 
complex scenario, there is likely no lack of opportunity on the horizon given the growth of 
technology transfers and more complex products (including advanced therapies). 
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